🇺🇸 FDA
Pipeline program

JZP-258

15-006

Phase 3 small_molecule completed

Quick answer

JZP-258 for Narcolepsy With Cataplexy is a Phase 3 program (small_molecule) at Jazz Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).

Program details

Company
Jazz Pharmaceuticals plc
Indication
Narcolepsy With Cataplexy
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials